Format

Send to

Choose Destination
Lancet Respir Med. 2018 Apr;6(4):242-244. doi: 10.1016/S2213-2600(18)30050-X.

Tuberculosis research and development: seeding the future.

Author information

1
Global TB Programme, WHO, Geneva 1211, Switzerland. Electronic address: lienhardtc@who.int.
2
Centre for Clinical Microbiology, Division of Infection and Immunity, University College London, London, UK; NIHR Biomedical Research Centre, UCL Hospitals NHS Foundation Trust, London, UK.
3
Global TB Programme, WHO, Geneva 1211, Switzerland.
4
Treatment Action Group, New York, NY, USA.
5
Medical Research Council South Africa, Cape Town, South Africa.
6
Prévessin-Moëns, France.
PMID:
29595503
DOI:
10.1016/S2213-2600(18)30050-X
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center